■离散选择实验(DCE)和概况案例(案例2)最佳-最差缩放(BWS)在量化个人医疗保健偏好的可接受性方面存在不确定性,这可能会对反应的有效性产生不利影响,并阻碍真实医疗保健偏好的反映。本研究旨在从2型糖尿病(T2DM)患者的角度评估这两种方法的可接受性,并检查其与目标人群特定特征的关系。
■这项横断面研究基于一项具有全国代表性的调查;数据是在2021年9月至2022年1月之间使用多阶段分层整群抽样程序收集的。确诊为T2DM的合格成人自愿参与本研究。参与者以随机顺序完成DCE和案例2BWS(BWS-2)选择任务,并提供自我报告的可接受性评估,包括任务完成难度,理解任务的复杂性,和响应偏好。使用Logistic回归和随机森林模型来识别与可接受性相关的变量。
■总共,3286名T2DM患者纳入研究。受访者表示,DCE和BWS-2之间的完成难度没有统计学上的显着差异,尽管DCE得分略高(3.07±0.68vs3.03±0.67,P=0.06)。然而,1979年(60.2%)的受访者认为DCE更容易理解。在两种方法之间没有观察到明显的偏好(1638(49.8%)对1648(50.2%))。社会人口因素,如住宅,每月自付费用,疾病持续时间与理解复杂性和反应偏好显著相关。
■这项研究与以前的大多数研究结果形成了对比,提示从DCE和BWS自我报告的可接受性来看,DCE可能对认知要求较低,更适合T2DM患者。这项研究促进了对患者可接受性的关注,以量化个人医疗保健偏好,从而为目标人群提供量身定制的最佳陈述偏好方法。
陈述的偏好方法,如离散选择实验(DCE)和案例2最佳-最差缩放(BWS-2)作为量化医疗保健中个人偏好的方法越来越受欢迎。然而,在实践中必须考虑两种方法对参与者的可接受性,以减轻认知负担并确保偏好启发的有效性。DCE被认为比BWS-2的认知负担更少。与认为DCE更可接受的患者相反,BWS-2更被农村患者接受,长期患有这种疾病的患者,以及那些每月自付费用较低的人。这些发现表明DCE和BWS-2对2型糖尿病患者的可接受性存在潜在差异。为了提高效率,研究人员根据社会人口统计学和疾病相关特征考虑最佳的陈述偏好方法来识别目标人群将是有用的.
UNASSIGNED: Discrete choice experiment (DCE) and profile case (case 2) best-worst scaling (BWS) present uncertainties regarding the acceptability of quantifying individual healthcare preferences, which may adversely affect the validity of responses and impede the reflection of true healthcare preferences. This study aimed to assess the acceptability of these two methods from the perspective of patients with type 2 diabetes mellitus (T2DM) and examine their association with specific characteristics of the target population.
UNASSIGNED: This cross-sectional study was based on a nationally representative survey; data were collected using a multistage stratified cluster-sampling procedure between September 2021 and January 2022. Eligible adults with confirmed T2DM voluntarily participated in this study. Participants completed both the DCE and case 2 BWS (BWS-2) choice tasks in random order and provided self-reported assessments of acceptability, including task completion difficulty, comprehension of task complexity, and response preference. Logistic regression and random forest models were used to identify variables associated with acceptability.
UNASSIGNED: In total, 3286 patients with T2DM were included in the study. Respondents indicated there was no statistically significant difference in completion difficulty between the DCE and BWS-2, although the DCE scores were slightly higher (3.07 ± 0.68 vs 3.03 ± 0.67, P = 0.06). However, 1979 (60.2%) respondents found the DCE easier to comprehend. No significant preferences were observed between the two methods (1638 (49.8%) vs 1648 (50.2%)). Sociodemographic factors, such as residence, monthly out-of-pocket costs, and illness duration were significantly associated with comprehension complexity and response preference.
UNASSIGNED: This study yielded contrasting results to most of previous studies, suggesting that DCE may be less cognitively demanding and more suitable for patients with T2DM from the perspective of self-reported acceptability of DCE and BWS. This study promotes a focus on patient acceptability in quantifying individual healthcare preferences to inform tailored optimal stated-preference method for a target population.
Stated preference methodologies such as the discrete choice experiment (DCE) and case 2 best-worst scaling (BWS-2) are gaining popularity as methods for quantifying individual preferences in healthcare. However, the acceptability of the two methods to participants must be considered in practice to reduce cognitive burden and ensure the validity of preference elicitation.DCE was perceived to be less cognitively burdensome than BWS-2. In contrast to patients who thought that DCE was more acceptable, BWS-2 was more accepted by rural patients, patients who lived with the disease for a longer period, and those who had lower monthly out-of-pocket costs.These findings demonstrate potential differences in the acceptability of DCE and BWS-2 for patients with type 2 diabetes mellitus. To improve efficiency, it would be useful for researchers to consider the optimal stated preference method for identifying target populations according to sociodemographic and disease-related characteristics.